Real Estate / REIT - Healthcare FacilitiesNYSE American
$12.98
-0.14 (-1.07%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 100% · confianza 20%
FCF escenarios
weak_data · normalized FCF n/d · quality 95.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
51/100
C
Piotroski
7/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
20/100
SEC 0%
Sin guardar todavía.
Market Cap
$174M
P/E
20.3x
↑EV/EBITDA
7.1x
↓ROE
62.6%
↑Gross Margin
89.8%
↑Debt/Equity
65.37
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2021–2025 · 4 años de histórico normalizado
Revenue CAGR
+15.5%
FCF CAGR
—
FCF margin
58.1%
FCF / Net income
11.89x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $155.0M · net income $7.6M · FCF $90.0M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | $155.0M | $155.0M | $117.1M | $99.8M | $92.5M | $87.0M |
| Net Income | $7.6M | $7.6M | $4.1M | $2.5M | $1.9M | $393000.00 |
| EBITDA | $130.1M | $130.1M | $94.3M | $75.2M | $66.4M | $64.2M |
| EPS | 0.60 | 0.60 | 0.57 | 0.39 | 0.31 | 0.07 |
| Gross Margin | 89.8% | 89.8% | 87.0% | 85.0% | 85.2% | — |
| Operating Margin | 53.4% | 53.4% | 51.0% | 48.3% | 52.1% | 42.2% |
| Net Margin | 4.9% | 4.9% | 3.5% | 2.5% | 2.0% | 0.5% |
| Balance Sheet | ||||||
| Debt/Equity | 65.37 | 65.37 | 36.97 | 71.66 | 58.73 | — |
| Current Ratio | 0.47 | 0.47 | — | — | — | — |
| Cash Flow | ||||||
| Free Cash Flow | $90.0M | $90.0M | $35.3M | $54.9M | $50.9M | — |
| Returns | ||||||
| ROE | 62.6% | 62.6% | 22.5% | 33.2% | 23.8% | 17.4% |
| Valuation | ||||||
| P/E | 20.28 | 20.28 | 18.79 | 20.27 | — | — |
| EV/EBITDA | 7.11 | 7.11 | 7.42 | 7.66 | — | — |
| P/B | 13.61 | 13.61 | 4.20 | 6.70 | — | — |
| Growth & Yield | ||||||
| Revenue Growth | 32.4% | 32.4% | 17.3% | 7.8% | — | — |
| EPS Growth | 5.3% | 5.3% | 46.2% | 25.8% | — | — |
| Dividend Yield | 5.2% | 5.2% | — | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
24.3%
EPS terminal req.
$1.15
Spread vs growth
-19.0%
5Y implied EPS CAGR
18.4%
EPS terminal req.
$1.39
Spread vs growth
-13.1%
10Y implied EPS CAGR
14.1%
EPS terminal req.
$2.24
Spread vs growth
-8.8%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+32.5%
Start / end P/E
17.9x → 21.6x
EPS bridge
0.57 → 0.60
Residual
+1.1%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.